M.D., M.B.A.
Medical Oncologist
2018-2020, M.B.A., University of North Carolina Kenan-Flagler School of Business, Chapel Hill, NC
1996, M.D. and Honors Program in Medical Education, Northwestern University, Chicago, IL
1992, B.S., Northwestern University, Evanston, IL
2019-present, Fellow of the American Society of Clinical Oncology
2015-present, Fellow of the American College of Physicians
1999-2001, Medical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX
1996-1999, Clinical Fellowship, Baylor College of Medicine, Houston, TX
2020-present, Physician-in-Chief, City of Hope Orange County, Irvine, CA
2020-present, Vice Physician-in-Chief, City of Hope National Medical Center, Professor, Department of Medical Oncology & Therapeutics Research, Duarte, CA
2012-2020, Chairman, Solid Tumor Oncology and Investigational Therapeutics, Donald S. Kim Distinguished Chair for Cancer Research, and
Medical Director, Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, and Professor of Medicine, University of North Carolina, Chapel Hill, NC
2002-2012, Associate Professor (tenured), Chief, Section of Head and Neck Medical Oncology, and Director, Clinical Research Operations, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Edward S. Kim, M.D., M.B.A., is the physician-in-chief for City of Hope’s® Orange County Lennar Foundation Cancer Center and vice-physician-in-chief for the City of Hope national network. A world-renowned expert in lung cancer and thoracic oncology, Dr. Kim serves in a pivotal leadership position that is charged with expanding access to advanced care—including clinical trials—for patients across Southern California, leading strategic clinical initiatives focusing on equity in cancer care and fostering multidisciplinary research collaborations.
Recognized by U.S. News & World Report as a “top doctor,” Dr. Kim is internationally known for his clinical work and his commitment to translating leading-edge discoveries into new cancer therapies that improve patient outcomes. His research focus is in molecular prognostication for lung, head and neck cancers, and he has published more than 200 publications in leading journals such as The Lancet, Journal of Clinical Oncology, Cancer Discovery and Nature Medicine. He has served as principal or co-principal investigator on numerous high-impact clinical trials and translational research projects.
Prior to joining City of Hope, Dr. Kim held multiple senior leadership positions at Levine Cancer Institute, including Chair of Solid Tumor Oncology, Medical Director of the Clinical Trials Office, and the Donald S. Kim Distinguished Chair for Cancer Research. He also held academic appointments at the University of North Carolina at Chapel Hill and was a tenured associate professor at MD Anderson Cancer Center in Houston, Texas. He also earned an M.B.A. at the University of North Carolina’s Kenan-Flagler Business School in Chapel Hill.